Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genmab Earns GSK Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Genmab Earns GSK Milestone

Files NDA in Japan for Arzerra

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genmab A/S has received a $3.4 million milestone payment from GlaxoSmithKline related to the filing of the NDA to the Japanese Ministry of Health, Labor and Welfare (MHLW). The NDA is for Arzerra (ofatumumab) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received prior therapy.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics